5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
- PMID: 1348296
- DOI: 10.1016/0140-6736(92)90927-u
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
Abstract
The incidence of prostate cancer varies widely between countries and ethnic groups. Black-Americans have the highest incidence rates world wide, whereas native Japanese have among the lowest. The reasons for this risk differential are unknown, although we have previously shown that higher circulating testosterone concentrations in young adult black men compared with young adult white men may explain the underlying differences in subsequent prostate cancer incidence between these two populations. We have now compared serum testosterone concentrations in young adult Japanese men with those of young adult whites and blacks, but found no significant differences. However, these white and black men had significantly higher values of 3 alpha, 17 beta androstanediol glucuronide (31% and 25% higher, respectively) and androsterone glucuronide (50% and 41% higher, respectively) than Japanese subjects. These two androgens are indices of 5 alpha-reductase activity. Our results raise the possibility that reduced 5 alpha-reductase activity has a role in producing the low prostate cancer incidence rates among Japanese. This finding may have important implications for prostate cancer prevention.
Similar articles
-
Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):533-8. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352865
-
Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):735-41. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8672990
-
Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.Cancer Causes Control. 2013 Apr;24(4):817-26. doi: 10.1007/s10552-013-0154-8. Epub 2013 Jan 25. Cancer Causes Control. 2013. PMID: 23354421 Free PMC article.
-
Serum selenium and risk of prostate cancer in U.S. blacks and whites.Int J Cancer. 2003 Feb 20;103(5):664-70. doi: 10.1002/ijc.10866. Int J Cancer. 2003. PMID: 12494476 Review.
-
Prostate cancer in black and white Americans.Cancer Metastasis Rev. 2003 Mar;22(1):83-6. doi: 10.1023/a:1022216119066. Cancer Metastasis Rev. 2003. PMID: 12716039 Review.
Cited by
-
Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer.Prostate Cancer. 2011;2011:754382. doi: 10.1155/2011/754382. Epub 2010 Nov 7. Prostate Cancer. 2011. PMID: 22110999 Free PMC article.
-
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.Cancer. 2016 Aug 1;122(15):2332-40. doi: 10.1002/cncr.30071. Epub 2016 May 10. Cancer. 2016. PMID: 27164191 Free PMC article.
-
The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level.Br J Cancer. 1999 Sep;81(1):184-5. doi: 10.1038/sj.bjc.6690670. Br J Cancer. 1999. PMID: 10487632 Free PMC article. No abstract available.
-
Screening for prostate cancer in African Americans.Curr Urol Rep. 2000 May;1(1):57-64. doi: 10.1007/s11934-000-0036-y. Curr Urol Rep. 2000. PMID: 12084342 Review.
-
Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.J Clin Pathol. 1999 Nov;52(11):793-803. doi: 10.1136/jcp.52.11.793. J Clin Pathol. 1999. PMID: 10690166 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical